Dr. Michael Thakor
Claim this profileGSK Investigational Site
Studies Arthritis
Studies Rheumatoid Arthritis
8 reported clinical trials
14 drugs studied
Affiliated Hospitals
Clinical Trials Michael Thakor is currently running
New Vaccine
for Flu
The aim of this study is to evaluate the safety, reactogenicity and immunogenicity of the Flu Pandemic messenger RNA (mRNA) vaccine (including dose-finding and dose-confirmation) administered healthy adults 18 to 85 years of age.
Recruiting0 awards Phase 1 & 23 criteria
Vagus Nerve Stimulation
for Rheumatoid Arthritis
The RESET-RA study will assess the safety and efficacy of the SetPoint System (study device) for the treatment of adult patients with active, moderate to severe rheumatoid arthritis who have had an inadequate response or intolerance to biologic or targeted synthetic Disease-Modifying Anti-Rheumatic Drugs (DMARDs). The study device contains a miniaturized stimulator (implant) that is surgically placed under general anesthesia on the vagus nerve through a small incision on the left side of the neck (implant procedure). The study will enroll 250 subjects at 40 sites. All eligible subjects will undergo the implant procedure. Half of the subjects will receive active stimulation (treatment) and the other half will receive non-active stimulation (control). After completing primary endpoint assessments at Week 12, there will be a one-way crossover of control subjects to active stimulation and a 180-week open-label follow-up with all subjects (treatment and control) receiving active stimulation to evaluate long-term safety.
Recruiting1 award Phase 34 criteria
More about Michael Thakor
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Michael Thakor has experience with
- Tildrakizumab
- Otilimab (GSK3196165)
- GSK3196165 (Otilimab)
- Tofacitinib
- Placebo To GSK3196165 (Otilimab)
- Placebo To Tofacitinib
Breakdown of trials Michael Thakor has run
Arthritis
Rheumatoid Arthritis
Psoriatic Arthritis
Connective Tissue Disease
Autoimmune Diseases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Thakor specialize in?
Michael Thakor focuses on Arthritis and Rheumatoid Arthritis. In particular, much of their work with Arthritis has involved treating patients, or patients who are undergoing treatment.
Is Michael Thakor currently recruiting for clinical trials?
Yes, Michael Thakor is currently recruiting for 3 clinical trials in Fort Collins Colorado. If you're interested in participating, you should apply.
Are there any treatments that Michael Thakor has studied deeply?
Yes, Michael Thakor has studied treatments such as Tildrakizumab, Otilimab (GSK3196165), GSK3196165 (Otilimab).
What is the best way to schedule an appointment with Michael Thakor?
Apply for one of the trials that Michael Thakor is conducting.
What is the office address of Michael Thakor?
The office of Michael Thakor is located at: GSK Investigational Site, Fort Collins, Colorado 80528 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.